2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$154.25-$0.07 (-0.05%)
Price as of Aug 21, 2026 7:56 PM EDT- $10.0BMarket Cap
- 168.48%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$154.25-$0.07 (-0.05%)
PTGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $154.32 | ||
Change | +$3.63 (+2.41%) | ||
Open | $152.10 | ||
High | $154.95 | ||
Low | $150.82 | ||
Previous Close | $150.69 | ||
Volume | 402,542 | ||
30-Day Average Volume | 499,074 | ||
1-Week Change | -0.50% | ||
1-Month Change | 11.58% | ||
1-Year Change | 168.48% | ||
3-Year Change | 690.17% | ||
5-Year Change | 213.53% | ||
Fundamentals | |||
Shares Outstanding | 64.7M | ||
Total Assets | $885.5M | ||
Market Cap | $10.0B | ||
Enterprise Value | $9.6B | ||
Period: QTR TTM FY | |||
Revenue | $213.5M | ||
Net Income | $162.8M | ||
Free Cash Flow | $218.9M | ||
EBIT | $165.1M | ||
EBITDA | $165.5M | ||
Net Working Capital | $770.0M | ||
EPS | $2.29 | ||
Enterprise Value/EBITDA | 58 | ||
Enterprise Value/Revenue | 45 | ||
P/B | 12 | ||
P/E | 67 | ||
PEG | 0 | ||
Price/Free Cash Flow | 46 | ||
Price/Operating Cash Flow | 46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue